Skip to main content
. 2016 Sep;106(9):1573–1581. doi: 10.2105/AJPH.2016.303338

TABLE 3—

List of Selected Outcomes Studied in the Nurses’ Health Study and Estimates of Total Available Cases

Total Events, No.
Outcome NHS NHS II Reference (See Online Appendix)
General
 Total mortality 22 800 2 600 Kawachi et al. (1993)
 Weight All participants All participants Fine et al. (1999)
 Incident diabetes 17 500 9 000 Hu et al. (2001)
 Incident primary hyperparathyroidism 350 NC Vaidya et al. (2015)
 Incident kidney stones 1 500 1 800 Ferraro et al. (2014)
 Incident depression (diagnosis and treatment) 11 500 12 500 Chang et al. (2016)
Cancer outcomes
 Incident breast cancer 13 000 5 300 Hankinson et al. (1998)
 Incident colorectal cancer 3 000 400 Giovannucci et al. (1995)
 Incident endometrial (uterine) cancer 2 000 700 De Vivo et al. (2002)
 Incident pancreatic cancer 800 50 Michaud et al. (2001)
 Incident lung cancer 3 600 250 Feskanich et al. (2000)
 Incident squamous cell skin cancer 2 400 500 Siiskonen et al. (2016)
 Incident basal cell skin cancer 23 700 8 900 Wu et al. (2015)
 Incident ovarian cancer 1 300 290 Hankinson et al. (1995)
 Incident bladder cancer 800 70 McGrath et al. (2007)
 Incident kidney and ureter cancer 500 200 Cho et al. (2013)
 Incident esophageal cancer 170 20 Song et al. (2016)
 Incident brain cancer 300 30 Holick et al. (2007)
 Incident Hodgkin’s lymphoma 100 50 Abel et al. (2010)
 Incident non-Hodgkin’s lymphoma 1 400 400 Zhang et al. (2000)
 Incident melanoma 1 200 500 Wu et al. (2015)
 Incident multiple myeloma 300 40 Birmann et al. (2007)
 Incident leukemia 250 80 Schernhammer et al. (2012)
Cardiovascular
 Incident myocardial infarction 7 000 700 Mukamal et al. (2005)
 Incident hypertension 76 000 25 300 Forman et al. (2008)
 Incident stroke 2 500 700 Rexrode et al. (1997)
 Incident sudden cardiac death 500 NC Chiuve et al. (2011)
 Incident peripheral artery disease 140 NC Bertoia et al. (2013)
Eyes and eyesight
 Incident glaucoma 1 000 NC Kang et al. (2010)
 Incident macular degeneration 1 800 NC Cho et al. (2000)
 Incident cataracts 4 200 NC Chasen-Taber et al. (1999)
Gastrointestinal
 Incident polyps Platz et al. (2000)
 Adenoma only 5 200 3 800
 Hyperplastic only 3 100 3 300
 Adenoma and hyperplastic 1 300 900
 Incident gastrointestinal bleeding 1 700 800 Huang et al. (2011)
 Incident ulcerative colitis 340 (NHS and NHS II combined) Ananthakrishnan et al. (2012)
 Incident Crohn’s disease 270 (NHS and NHS II combined) Ananthakrishnan et al. (2012)
Gynecologic
 Gestational diabetes NC 6 000 Zhang et al. (2014)
 Incident infertility NC 3 200 Chavarro et al. (2007)
 Incident pregnancy loss (spontaneous abortion and stillbirth) NC 4 500 Gaskins et al. (2014)
 Incident endometriosis NC 5 500 Shah et al. (2013)
 Incident uterine leiomyomata NC 9 800 Terry et al. (2010)
 Incident benign breast disease (centrally reviewed) NC 2 000 Liu et al. (2013)
 Premenstrual syndrome NC 1 300 Bertone-Johnson et al. (2015)
Neurologic
 Cognitive function 19 400 NC Weuve et al. (2004)
 Incident amyotrophic lateral sclerosis 150 NC Wang et al. (2011)
 Incident multiple sclerosis 210 350 Munger et al. (2003)
 Incident Parkinson’s disease 700 80 Simon et al. (2007)
 Incident seizures or epilepsy NC 250 Dworetzky et al. (2010)
 Incident hearing loss 19 000 12 000 Curhan et al. (2015)
 Restless leg syndrome 900 4 200 Li et al. (2012)
Pulmonary
 Incident chronic obstructive pulmonary disease 5 700 2 500 Varraso et al. (2007)
 Incident asthma 15 500 21 100 Camargo et al. (1999)
 Incident pulmonary embolism 1 600 700 Kabrhel et al. (2011)
 Incident pneumonia NC 1 200 Neuman et al. (2010)
Autoimmune and musculoskeletal disorders
 Incident gout 1 000 370 Hak et al. (2010)
 Incident psoriasis 1 600 1 600 Wu et al. (2014)
 Incident systemic lupus erythematosus 200 130 Costenbader et al. (2007)
 Incident rheumatoid arthritis 1 000 500 Sparks et al. (2016)
 Incident hip fractures 3 400 700 Meyer et al. (2016)

Note. NC = not collected; NHS = Nurses’ Health Study. The table shows approximate estimates. The number of cases used in a specific study depends on the disease definition used, start of follow-up used, and the number of exclusions (e.g., missing the exposure). Outcome assessment start time and methods are not always consistent across endpoints and between cohorts.